Dark Forest Capital Management’s Niagen Bioscience NAGE Stock Holding History

Dark Forest Capital Management’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-190,085	Closed	-$1.77M	–	1428
2025 Q3	$1.77M	Buy	190,085 +138,752	+270%	+$1.4M	0.07%	506
2025 Q2	$740K	Buy	51,333 +39,902	+349%	+$394K	0.03%	836
2025 Q1	$78.9K	Buy	+11,431	New	+$71.8K	﹤0.01%	1180

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Dark Forest Capital Management's NAGE Position: Q4 2025 in Review

Dark Forest Capital Management sold out of Niagen Bioscience (NAGE) in Q4 2025, closing a stake of 190,085 shares — an estimated $1.77M sold.

Dark Forest Capital Management first reported a position in NAGE in Q1 2025 and held it in 3 quarters. The position peaked at $1.77M in Q3 2025. 169 funds tracked by Wall St. Rank hold NAGE as of Q4 2025.

Dark Forest Capital Management reported no remaining Niagen Bioscience position as of Q4 2025 after selling out during the quarter.
Dark Forest Capital Management sold 190,085 Niagen Bioscience shares in Q4 2025, an estimated $1.77M.
Dark Forest Capital Management first reported a position in Niagen Bioscience in Q1 2025 and held it in 3 quarters.
Dark Forest Capital Management's Niagen Bioscience position peaked at $1.77M in Q3 2025.
169 funds tracked by Wall St. Rank held Niagen Bioscience as of Q4 2025.

Based on Dark Forest Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.